Ablation Reboots the Response in Advanced Hepatocellular Carcinoma With Stable or Atypical Response During PD-1 Therapy: A Proof-of-Concept Study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ablation Reboots the Response in Advanced Hepatocellular Carcinoma With Stable or Atypical Response During PD-1 Therapy: A Proof-of-Concept Study
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-10-14
DOI
10.3389/fonc.2020.580241
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Percutaneous Ablation-Induced Immunomodulation in Hepatocellular Carcinoma
- (2020) Lucile Dumolard et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Andrew X Zhu et al. LANCET ONCOLOGY
- Combined locoregional-immunotherapy for liver cancer
- (2019) Tim F. Greten et al. JOURNAL OF HEPATOLOGY
- Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade
- (2019) Ying Zhu et al. GUT
- Results of KEYNOTE-240: phase 3 study of pembrolizumab (Pembro) vs best supportive care (BSC) for second line therapy in advanced hepatocellular carcinoma (HCC).
- (2019) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Hepatocellular Carcinoma
- (2019) Augusto Villanueva NEW ENGLAND JOURNAL OF MEDICINE
- Immunotherapy and the Interventional Oncologist: Challenges and Opportunities—A Society of Interventional Oncology White Paper
- (2019) Joseph P. Erinjeri et al. RADIOLOGY
- Immune checkpoint inhibitors for hepatocellular carcinoma
- (2019) Imane El Dika et al. CANCER
- TOX is a critical regulator of tumour-specific T cell differentiation
- (2019) Andrew C. Scott et al. NATURE
- Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non–Small Cell Lung Cancer
- (2019) Willemijn S. M. E. Theelen et al. JAMA Oncology
- Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma
- (2018) Valerie Chew et al. GUT
- Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification
- (2018) Yutaka Kurebayashi et al. HEPATOLOGY
- Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations
- (2018) Jean-Charles Nault et al. JOURNAL OF HEPATOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- CT-guided percutaneous radiofrequency ablation for lung neoplasms adjacent to the pericardium
- (2018) Luwen Mu et al. LUNG CANCER
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
- (2018) Ghassan K. Abou-Alfa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Design and conduct of early clinical studies of immunotherapy agent combinations: Recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies
- (2018) M Smoragiewicz et al. ANNALS OF ONCOLOGY
- The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy
- (2018) Mehmet A. Bilen et al. CANCER
- Tremelimumab in combination with microwave ablation in patients with refractory biliary tract cancer
- (2018) Changqing Xie et al. HEPATOLOGY
- Time to abandon single-site irradiation for inducing abscopal effects
- (2018) Eric D. Brooks et al. Nature Reviews Clinical Oncology
- Percutaneous CT-guided radiofrequency ablation for patients with extrahepatic oligometastases of hepatocellular carcinoma: long-term results
- (2017) Luwen Mu et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
- (2017) Austin G. Duffy et al. JOURNAL OF HEPATOLOGY
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Effects of microwave ablation on T-cell subsets and cytokines of patients with hepatocellular carcinoma
- (2017) Haiwen Zhang et al. MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES
- Changes in peripheral blood T-cell balance after percutaneous tumor ablation
- (2017) Haruyuki Takaki et al. MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES
- Percutaneous CT-guided Radiofrequency Ablation for Lymph Node Oligometastases from Hepatocellular Carcinoma: A Propensity Score–matching Analysis
- (2017) Tao Pan et al. RADIOLOGY
- Ramucirumab as Second-Line Treatment in Patients With Advanced Hepatocellular Carcinoma
- (2017) Andrew X. Zhu et al. JAMA Oncology
- PD-1 Blockade Boosts Radiofrequency Ablation-Elicited Adaptive Immune Responses against Tumor
- (2016) L. Shi et al. CLINICAL CANCER RESEARCH
- Localized and Systemic Approaches to Treating Hepatocellular Carcinoma
- (2015) Jennifer J. Knox et al. JOURNAL OF CLINICAL ONCOLOGY
- Image-Guided Tumor Ablation: Standardization of Terminology and Reporting Criteria—A 10-Year Update: Supplement to the Consensus Document
- (2014) Muneeb Ahmed JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Developing a Common Language for Tumor Response to Immunotherapy: Immune-Related Response Criteria Using Unidimensional Measurements
- (2013) M. Nishino et al. CLINICAL CANCER RESEARCH
- Enhancement of tumor-associated antigen-specific T cell responses by radiofrequency ablation of hepatocellular carcinoma
- (2012) Eishiro Mizukoshi et al. HEPATOLOGY
- Radiofrequency Thermal Ablation for Hepatocellular Carcinoma Stimulates Autologous NK-Cell Response
- (2010) Alessandro Zerbini et al. GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started